0000950170-24-022120.txt : 20240228 0000950170-24-022120.hdr.sgml : 20240228 20240228161842 ACCESSION NUMBER: 0000950170-24-022120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240226 FILED AS OF DATE: 20240228 DATE AS OF CHANGE: 20240228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Walker John D. III CENTRAL INDEX KEY: 0001843398 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33268 FILM NUMBER: 24695670 MAIL ADDRESS: STREET 1: C/O CENTRAL GARDEN & PET COMPANY STREET 2: 1340 TREAT BLVD STE 600 CITY: WALNUT CREEK STATE: CA ZIP: 94597 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CENTRAL GARDEN & PET CO CENTRAL INDEX KEY: 0000887733 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 680275553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0928 BUSINESS ADDRESS: STREET 1: 1340 TREAT BOULEVARD STREET 2: SUITE 600 CITY: WALNUT CREEK STATE: CA ZIP: 94597 BUSINESS PHONE: 9259484000 MAIL ADDRESS: STREET 1: 1340 TREAT BOULEVARD STREET 2: SUITE 600 CITY: WALNUT CREEK STATE: CA ZIP: 94597 FORMER COMPANY: FORMER CONFORMED NAME: CENTRAL GARDEN & PET COMPANY DATE OF NAME CHANGE: 19941019 4 1 ownership.xml 4 X0508 4 2024-02-26 0000887733 CENTRAL GARDEN & PET CO CENT 0001843398 Walker John D. III 1340 TREAT BLVD SUITE 600 WALNUT CREEK CA 94597-7578 false true false false President, Garden Consumer Pro false Class A Common Stock 2024-02-26 4 M false 27856 21.76 A 105307 D Class A Common Stock 2024-02-26 4 F false 21562 36.86 D 83745 D Class A Common Stock 2024-02-26 4 M false 26316 22.80 A 110061 D Class A Common Stock 2024-02-26 4 F false 20780 36.86 D 89281 D Units 10105 I By 401(k) Plan Stock Option (Right to Buy) 21.76 2024-02-26 4 M false 27856 0 D 2025-02-13 Class A Common Stock 27856 0 D Stock Option (Right to Buy) 22.80 2024-02-26 4 M false 26316 0 D 2026-02-10 Class A Common Stock 26316 0 D On December 7, 2023, Company declared a stock dividend, payable to all holders on record of Common Stock and Class A Common Stock as of January 8, 2024, of one share of Class A Common Stock for every four shares of Common Stock and Class A Common Stock outstanding. At the same time, pursuant to anti-dilution provisions , an option for 22,285 shares Class A Common Stock on January 8, 2024 became exercisable for 27,856 shares of Class A Common Stock. Shares withheld by the Issuer in payment of the aggregate option exercise price and withholding tax liability incurred upon the above-reported exercise of options. The amount of shares withheld is based on the respective average of the high and low sales prices on the date of exercise. On December 7, 2023, Company declared a stock dividend, payable to all holders on record of Common Stock and Class A Common Stock as of January 8, 2024, of one share of Class A Common Stock for every four shares of Common Stock and Class A Common Stock outstanding. At the same time, pursuant to anti-dilution provisions , an option for 21,053 shares Class A Common Stock on January 8, 2024 became exercisable for 26,316 shares of Class A Common Stock. The units represent interests in the CENTA Stock Fund in the Issuer's 401(k) Plan, which consist of shares of CENTA stock and cash. This option was previously reported as an option for 22,285 shares of Class A Common Stock at an exercise price of $27.20 per share, but was adjusted to reflect the stock dividend declared by Company on December 7, 2023. As a result of the stock dividend, the option also entitled the Reporting Person to receive, upon exercise, 5,571 shares of Class A Common Stock for no additional consideration. Options were granted on February 13, 2019, and all shares are vested and have been exercised. This option was previously reported as an option for 21,053 shares of Class A Common Stock at an exercise price of $28.50 per share, but was adjusted to reflect the stock dividend declared by Company on December 7, 2023. As a result of the stock dividend, the option also entitled the Reporting Person to receive, upon exercise, 5,263 shares of Class A Common Stock for no additional consideration. Options were granted on February 10, 2020, and all shares are vested and have been exercised. /s/Filomena Eickstaedt as Attorney-in-Fact for John D. Walker III 2024-02-28